On the public citation graph

Discovery of a Novel Family of SARS-CoV Protease Inhibitors by Virtual Screening and 3D-QSAR Studies

0 signed · 112 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/(sici)1096-987x(19970715)18:9<1175::aid-jcc6>3.0.co;2-oopenalex-snapshot

Critical evaluation of search algorithms for automated molecular docking and database screening

inferredcites →https://doi.org/10.1002/1096-987x(200009)21:12<1049::aid-jcc3>3.0.co;2-fopenalex-snapshot

How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?

inferredcites →https://doi.org/10.1002/1097-0282(2000)56:4<275::aid-bip10024>3.0.co;2-eopenalex-snapshot

Theory and applications of the generalized born solvation model in macromolecular simulations

inferredcites →https://doi.org/10.1002/jcc.20035openalex-snapshot

Development and testing of a general amber force field

inferredcites →https://doi.org/10.1002/jcc.20186openalex-snapshot

SARS‐CoV protease inhibitors design using virtual screening method from natural products libraries

inferredcites →https://doi.org/10.1002/jcc.540040211openalex-snapshot

CHARMM : A program for macromolecular energy, minimization, and dynamics calculations

inferredcites →https://doi.org/10.1002/jcc.540160205openalex-snapshot

Poling: Promoting conformational variation

inferredcites →https://doi.org/10.1016/0040-4020(80)80168-2openalex-snapshot

Iterative partial equalization of orbital electronegativity—a rapid access to atomic charges

inferredcites →https://doi.org/10.1016/j.bbrc.2004.04.098openalex-snapshot

Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate

inferredcites →https://doi.org/10.1016/j.bmcl.2003.08.066openalex-snapshot

Identifying inhibitors of the SARS coronavirus proteinase

inferredcites →https://doi.org/10.1016/j.bmcl.2005.04.027openalex-snapshot

Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors

inferredcites →https://doi.org/10.1016/j.bmcl.2005.11.018openalex-snapshot

From genome to drug lead: Identification of a small-molecule inhibitor of the SARS virus

inferredcites →https://doi.org/10.1016/j.chembiol.2004.07.013openalex-snapshot

Identification of Novel Small-Molecule Inhibitors of Severe Acute Respiratory Syndrome-Associated Coronavirus by Chemical Genetics

inferredcites →https://doi.org/10.1016/j.chembiol.2004.08.011openalex-snapshot

High-Throughput Screening Identifies Inhibitors of the SARS Coronavirus Main Proteinase

inferredcites →https://doi.org/10.1016/j.ejmech.2004.09.013openalex-snapshot

Generation of predictive pharmacophore model for SARS-coronavirus main proteinase

inferredcites →https://doi.org/10.1016/s0006-291x(03)01342-1openalex-snapshot

Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS

inferredcites →https://doi.org/10.1016/s0022-2836(03)00865-9openalex-snapshot

Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage

inferredcites →https://doi.org/10.1021/bi0361766openalex-snapshot

Identification of Novel Inhibitors of the SARS Coronavirus Main Protease 3CLpro

inferredcites →https://doi.org/10.1021/ci034270nopenalex-snapshot

Virtual Screening for SARS-CoV Protease Based on KZ7088 Pharmacophore Points

inferredcites →https://doi.org/10.1021/ci049809bopenalex-snapshot

Virtual Screening of Novel Noncovalent Inhibitors for SARS-CoV 3C-like Proteinase

inferredcites →https://doi.org/10.1021/j100142a004openalex-snapshot

A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model

inferredcites →https://doi.org/10.1021/ja00124a002openalex-snapshot

A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules

inferredcites →https://doi.org/10.1021/ja00226a005openalex-snapshot

Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins

inferredcites →https://doi.org/10.1021/je60033a020openalex-snapshot

A brief review and table of semiempirical parameters used in the Hueckel molecular orbital method

inferredcites →https://doi.org/10.1021/jm034137mopenalex-snapshot

Sabadinine: A Potential Non-Peptide Anti-Severe Acute-Respiratory-Syndrome Agent Identified Using Structure-Aided Design

inferredcites →https://doi.org/10.1021/jm0501782openalex-snapshot

A New Lead for Nonpeptidic Active-Site-Directed Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus Main Protease Discovered by a Combination of Screening and Docking Methods

inferredcites →https://doi.org/10.1056/nejmc031427openalex-snapshot

A Novel Coronavirus and SARS

inferredcites →https://doi.org/10.1056/nejmoa030634openalex-snapshot

Identification of Severe Acute Respiratory Syndrome in Canada

inferredcites →https://doi.org/10.1056/nejmoa030685openalex-snapshot

A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong

inferredcites →https://doi.org/10.1056/nejmp030078openalex-snapshot

SARS-Associated Coronavirus

inferredcites →https://doi.org/10.1056/nejmp030080openalex-snapshot

SARS and Carlo Urbani

inferredcites →https://doi.org/10.1073/pnas.0403596101openalex-snapshot

Small molecules targeting severe acute respiratory syndrome human coronavirus

inferredcites →https://doi.org/10.1073/pnas.1835675100openalex-snapshot

The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

inferredcites →https://doi.org/10.1074/jbc.m408211200openalex-snapshot

Severe Acute Respiratory Syndrome Coronavirus 3C-like Proteinase N Terminus Is Indispensable for Proteolytic Activity but Not for Enzyme Dimerization

inferredcites →https://doi.org/10.1093/ecam/neh081openalex-snapshot

Inhibition of SARS‐CoV 3C‐like Protease Activity by Theaflavin‐3,3′‐digallate (TF3)

inferredcites →https://doi.org/10.1093/emboj/cdf327openalex-snapshot

Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α‐helical domain

inferredcites →https://doi.org/10.1099/vir.0.19424-0openalex-snapshot

Mechanisms and enzymes involved in SARS coronavirus genome expression

inferredcites →https://doi.org/10.1126/science.1082240openalex-snapshot

Stress-Induced Mutagenesis in Bacteria

inferredcites →https://doi.org/10.1126/science.1085658openalex-snapshot

Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS Drugs

inferredcites →https://doi.org/10.1126/science.1085952openalex-snapshot

Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

inferredcites →https://doi.org/10.1126/science.1085953openalex-snapshot

The Genome Sequence of the SARS-Associated Coronavirus

inferredcites →https://doi.org/10.1128/jvi.79.11.7095-7103.2005openalex-snapshot

Cinanserin Is an Inhibitor of the 3C-Like Proteinase of Severe Acute Respiratory Syndrome Coronavirus and Strongly Reduces Virus Replication In Vitro

inferredcites →https://doi.org/10.1524/zpch.1975.95.4-6.332openalex-snapshot

Statistical Mechanics

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/0471266949.bmc006.pub2openalex-snapshot

Virtual Screening

inferred← citeshttps://doi.org/10.1002/cben.201400031openalex-snapshot

Characterization and Inhibition of the Main Protease of Severe Acute Respiratory Syndrome Coronavirus

inferred← citeshttps://doi.org/10.1002/cmdc.202000223openalex-snapshot

Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics

inferred← citeshttps://doi.org/10.1002/rmv.2206openalex-snapshot

Innate immune evasion mediated by picornaviral 3C protease: Possible lessons for coronaviral 3C‐like protease?

inferred← citeshttps://doi.org/10.1007/7355_2009_3openalex-snapshot

Lead Discovery Using Virtual Screening

inferred← citeshttps://doi.org/10.1007/s13205-023-03745-2openalex-snapshot

In silico guided screening of active components of C. lanceolata as 3-chymotrypsin-like protease inhibitors of novel coronavirus

inferred← citeshttps://doi.org/10.1016/b978-0-12-809712-0.00011-3openalex-snapshot

Structural Insight Into the Viral 3C-Like Protease Inhibitors: Comparative SAR/QSAR Approaches

inferred← citeshttps://doi.org/10.1016/b978-0-443-18611-0.00023-1openalex-snapshot

Diarylpyrimidines and related analogs as antiviral agents

inferred← citeshttps://doi.org/10.1016/j.bcp.2020.114225openalex-snapshot

Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches

inferred← citeshttps://doi.org/10.1016/j.bioorg.2020.104315openalex-snapshot

Role of heterocyclic compounds in SARS and SARS CoV-2 pandemic

inferred← citeshttps://doi.org/10.1016/j.bj.2020.05.001openalex-snapshot

Artificial intelligence approach fighting COVID-19 with repurposing drugs

inferred← citeshttps://doi.org/10.1016/j.bmc.2007.09.034openalex-snapshot

Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV Mpro

inferred← citeshttps://doi.org/10.1016/j.bmc.2020.115745openalex-snapshot

Druggable targets from coronaviruses for designing new antiviral drugs

inferred← citeshttps://doi.org/10.1016/j.bmcl.2014.05.004openalex-snapshot

Pharmacophore based virtual screening, molecular docking and biological evaluation to identify novel PDE5 inhibitors with vasodilatory activity

inferred← citeshttps://doi.org/10.1016/j.chembiol.2008.04.011openalex-snapshot

A Structural View of the Inactivation of the SARS Coronavirus Main Proteinase by Benzotriazole Esters

inferred← citeshttps://doi.org/10.1016/j.compbiolchem.2020.107351openalex-snapshot

Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design

inferred← citeshttps://doi.org/10.1016/j.coviro.2014.06.002openalex-snapshot

Antiviral drugs specific for coronaviruses in preclinical development

inferred← citeshttps://doi.org/10.1016/j.ddtec.2006.12.002openalex-snapshot

Advances in virtual screening

inferred← citeshttps://doi.org/10.1016/j.ejmech.2021.113294openalex-snapshot

Protease targeted COVID-19 drug discovery: What we have learned from the past SARS-CoV inhibitors?

inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.115772openalex-snapshot

Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review

inferred← citeshttps://doi.org/10.1016/j.jconrel.2021.08.046openalex-snapshot

Nano-engineered tools in the diagnosis, therapeutics, prevention, and mitigation of SARS-CoV-2

inferred← citeshttps://doi.org/10.1016/j.pharmthera.2006.09.001openalex-snapshot

Protease inhibitors and their peptidomimetic derivatives as potential drugs

inferred← citeshttps://doi.org/10.1016/j.rechem.2021.100132openalex-snapshot

Triazole, imidazole, and thiazole-based compounds as potential agents against coronavirus

inferred← citeshttps://doi.org/10.1016/j.tips.2014.12.001openalex-snapshot

Beware of docking!

inferred← citeshttps://doi.org/10.1017/cbo9780511730412.009openalex-snapshot

Docking: a domesday report

inferred← citeshttps://doi.org/10.1021/acs.jcim.0c00326openalex-snapshot

Discovery of New Hydroxyethylamine Analogs against 3CLpro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure–Activity Relationship Studies

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c00409openalex-snapshot

Perspectives on SARS-CoV-2 Main Protease Inhibitors

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b01461openalex-snapshot

An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy

inferred← citeshttps://doi.org/10.1021/acs.jnatprod.5b00634openalex-snapshot

Antiviral Indolosesquiterpenoid Xiamycins C–E from a Halophilic Actinomycete

inferred← citeshttps://doi.org/10.1021/ci200088dopenalex-snapshot

Snooker: A Structure-Based Pharmacophore Generation Tool Applied to Class A GPCRs

inferred← citeshttps://doi.org/10.1021/jm060207oopenalex-snapshot

Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Main Protease

inferred← citeshttps://doi.org/10.1021/jm501567fopenalex-snapshot

Oleanane Triterpenes from the Flowers of Camellia japonica Inhibit Porcine Epidemic Diarrhea Virus (PEDV) Replication

inferred← citeshttps://doi.org/10.1039/9781847558879-00076openalex-snapshot

Pharmacophore-based Virtual Screening in Drug Discovery

inferred← citeshttps://doi.org/10.1039/d0ra04395hopenalex-snapshot

Targeting severe acute respiratory syndrome-coronavirus (SARS-CoV-1) with structurally diverse inhibitors: a comprehensive review

inferred← citeshttps://doi.org/10.1039/d1nj02127copenalex-snapshot

A computational approach for designing novel SARS-CoV-2 M pro inhibitors: combined QSAR, molecular docking, and molecular dynamics simulation techniques

inferred← citeshttps://doi.org/10.1042/bst0391371openalex-snapshot

Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discovery

inferred← citeshttps://doi.org/10.1080/07391102.2020.1821779openalex-snapshot

In silico modeling for quick prediction of inhibitory activity against 3CL pro enzyme in SARS CoV diseases

inferred← citeshttps://doi.org/10.1080/1062936x.2021.1975167openalex-snapshot

Suggestion of active 3-chymotrypsin like protease (3CL Pro ) inhibitors as potential anti-SARS-CoV-2 agents using predictive QSAR model based on the combination of ALASSO with an ANN model

inferred← citeshttps://doi.org/10.1097/mcp.0b013e3282f7646fopenalex-snapshot

Recent antiviral strategies against human coronavirus-related respiratory illnesses

inferred← citeshttps://doi.org/10.1101/314914openalex-snapshot

Identification of novel and structurally diverse N-Methyl-D-Aspartate Receptor Antagonists: Successful Application of Pharmacophore Modeling, Virtual Screening and Molecular Docking

inferred← citeshttps://doi.org/10.1107/s0108767307054426openalex-snapshot

The search for a structural basis for therapeutic intervention against the SARS coronavirus

inferred← citeshttps://doi.org/10.1111/febs.12936openalex-snapshot

From SARS to MERS : crystallographic studies on coronaviral proteases enable antiviral drug design

inferred← citeshttps://doi.org/10.1111/febs.15696openalex-snapshot

Overview of antiviral drug candidates targeting coronaviral 3C‐like main proteases

inferred← citeshttps://doi.org/10.1134/s107042802105002xopenalex-snapshot

Main Chemotypes of SARS-CoV-2 Reproduction Inhibitors

inferred← citeshttps://doi.org/10.1360/ssc-2020-0145openalex-snapshot

Advances in enzymatic activity regulation mechanism and inhibitor discovery of coronavirus 3C-like protease

inferred← citeshttps://doi.org/10.1517/13543776.17.5.533openalex-snapshot

Pharmacophores and biological activities of severe acute respiratory syndrome viral protease inhibitors

inferred← citeshttps://doi.org/10.1517/17460441.2.1.37openalex-snapshot

Combining ligand-based and structure-based drug design in the virtual screening arena

inferred← citeshttps://doi.org/10.1517/17460441003592072openalex-snapshot

Pharmacophore-based virtual screening: a review of recent applications

inferred← citeshttps://doi.org/10.18097/pbmc20226806444openalex-snapshot

The prediction of SARS-CoV-2 main protease inhibition with filtering by position of ligand

inferred← citeshttps://doi.org/10.2174/092986712802884259openalex-snapshot

Machine Learning Techniques and Drug Design

inferred← citeshttps://doi.org/10.25560/4269openalex-snapshot

Design, Synthesis and Analysis of FMDV 3C-Protease Inhibitors

inferred← citeshttps://doi.org/10.26434/chemrxiv.12090426openalex-snapshot

Computational Evaluation of the COVID-19 3c-like Protease Inhibition Mechanism, and Drug Repurposing Screening

inferred← citeshttps://doi.org/10.26434/chemrxiv.12090426.v1openalex-snapshot

Computational Evaluation of the COVID-19 3c-like Protease Inhibition Mechanism, and Drug Repurposing Screening

inferred← citeshttps://doi.org/10.26434/chemrxiv.12228362openalex-snapshot

New Potential Drug Candidates Against SARS-CoV-2 Using Generative Model

inferred← citeshttps://doi.org/10.26434/chemrxiv.12228362.v1openalex-snapshot